HYPERTENSION, PORTAL
Clinical trials for HYPERTENSION, PORTAL explained in plain language.
Never miss a new study
Get alerted when new HYPERTENSION, PORTAL trials appear
Sign up with your email to follow new studies for HYPERTENSION, PORTAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets liver vein pressure in cirrhosis patients
Disease control TerminatedThis study tested whether a medicine called Avenciguat (BI 685509), taken alone or with empagliflozin, could lower high blood pressure in the liver's main vein in adults with cirrhosis. About 90 people with cirrhosis from hepatitis or fatty liver disease were expected to join. Th…
Matched conditions: HYPERTENSION, PORTAL
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Liver pressure drug trial halted early
Disease control TerminatedThis study looked at whether a medicine called Avenciguat could lower high blood pressure in the main vein of the liver in adults with cirrhosis. Participants were randomly assigned to take either a low dose, a high dose, or a placebo (fake pill) twice a day for about 24 weeks. T…
Matched conditions: HYPERTENSION, PORTAL
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 11, 2026 20:50 UTC